Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
Novartis MS pill heads stream of SMC approvals
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
Multiple sclerosis drugs: how much bang for the buck?
In vivo histology of the myelin g-ratio with magnetic resonance imaging.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
The Neurite Outgrowth Inhibitory Nogo-A-Δ20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity.
Depression as a predictor of occupational transition in a multiple sclerosis cohort.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
Development of a nanomaterial bio-screening platform for neurological applications.
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Acute bilateral visual loss in a young adult.
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
IL-12, but not IL-23, induces the expression of IL-7 in microglia and macrophages: Implications for multiple sclerosis.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Optical Coherence Tomography for the Detection of Remote Optic Neuritis in Multiple Sclerosis.
Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
Pages
« first
‹ previous
…
390
391
392
393
394
395
396
397
398
…
next ›
last »